Definitive Contract 75F40122C00152
Award Date 9/20/22
Potential Completion Date 9/19/27
Potential Value $315K
Federal Agency
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Berwyn Heights, MD 20740, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Food and Drug Administration awarded a $736,000 firm fixed-price definitive contract to Pacific Biosciences of California, Inc. for a real-time sequencer system with four one-year post-warranty maintenance option periods. The contract, awarded on September 3, 2019, with an ultimate completion date of December 11, 2024, is designated as a Total Small Business set-aside. Pacific Biosciences, a leading biotechnology company specializing in advanced DNA and RNA sequencing technologies, will...
- The Department of Health and Human Services Food and Drug Administration awarded a $51,193.93 purchase order to Pacific Biosciences of California, Inc. for sequencing supplies. The firm fixed price contract runs from August 23, 2023 to February 19, 2024 and will be performed by Pacific Biosciences in West Menlo Park, California. The original solicitation sought sequencing supplies as described in Combined Synopsis Solicitation 75F40123Q-117934 to support the FDA's evaluation of new sequencing...
- The Food and Drug Administration (FDA) awarded a $336,000 firm fixed-price purchase order to Pacific Biosciences of California, Inc. on August 21, 2015, for Part Number 100-236-400, a standard PacBio service contract with a base period and four option years. The contract was completed on July 22, 2019, with performance undertaken at the contractor's facility in Menlo Park, California. No set-aside designation was applied to this award. Pacific Biosciences is a leading biotechnology company...
- The Department of Health and Human Services Food and Drug Administration awarded a $433,950.00 firm fixed price purchase order to Pacific Biosciences of California, Inc. to provide a DNA sequencer with accessories. The contract has no set-aside designation and was completed on August 29, 2019. Pacific Biosciences is a manufacturer of specialized scientific equipment, reagents, and services for DNA/RNA sequencing. They have fulfilled over $10 million in federal contracts, including with the...
- This is a firm fixed-price purchase order issued by the Department of Health and Human Services Food and Drug Administration to Pacific Biosciences of California, Inc., a small business manufacturer of specialized scientific equipment, reagents, and services. The $175,000.00 contract provides a service and maintenance agreement for Pacific Biosciences' Sequel and Sequel II DNA/RNA sequencing systems, including software updates and annual preventative maintenance visits. Pacific Biosciences has...
- This federal contract award to Pacific Biosciences of California, Inc. (PacBio) provides for the delivery of a PacBio RS DNA sequencing system with a 12-month service contract. The $998,000.00 firm fixed price contract was awarded by the Food and Drug Administration (FDA), a civilian agency, without the use of a set-aside. PacBio is the original equipment manufacturer for the PacBio Sequel and Sequel II sequencing platforms, which are in high demand across federal agencies for genomic research...
- This contract award to Pacific Biosciences of California, Inc., a small business manufacturer, is for the provision of high-throughput, long-read DNA sequencing systems and associated consumables to the U.S. Food and Drug Administration (FDA). The $83,644 firm fixed-price purchase order has an ultimate completion date of October 14, 2015. Pacific Biosciences is the original equipment manufacturer for their proprietary single molecule, real-time (SMRT) sequencing technology, which is utilized...
- The Food and Drug Administration awarded a $22.9K firm fixed-price purchase order to Pacific Biosciences of California, Inc., a Menlo Park-based biotechnology manufacturer specializing in advanced DNA and RNA sequencing technologies. The award, designated as a total small business set-aside, was executed on July 27, 2021, for SMRT cell 8M trays and Sequel II sequencing kits—consumable products essential for next-generation sequencing operations. The procurement was completed ahead of the October...
- This federal contract award is for the procurement of PacBio Sequel II and IIe system reagents and consumables by the Food and Drug Administration (FDA). The $15,713.10 firm-fixed price contract was awarded on July 23, 2024 to Pacific Biosciences of California, Inc., a leading manufacturer of high-throughput, long-read DNA sequencing platforms and associated products. The contract does not have a set-aside designation. Pacific Biosciences holds two relevant Indefinite Delivery Indefinite...
- This federal contract award to Pacific Biosciences of California, Inc. is a delivery order under an Indefinite Delivery Indefinite Quantity (IDIQ) contract #75F40121D00007 with the Food and Drug Administration (FDA). The purpose is to purchase specific supplies and reagents for the PacBio Sequel IIe long-read DNA/RNA sequencer. The award is for a firm fixed-price of $46,341.66, with a period of performance through May 30, 2025. Pacific Biosciences is the original equipment manufacturer for the...